Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies.
Tadeja KuretBlaž BurjaJulia FeichtingerGerhard G ThallingerMojca Frank-BertonceljKatja LakotaPolona ŽigonSnezna Sodin-SemrlSaša ČučnikMatija TomšičAlojzija HočevarPublished in: Clinical rheumatology (2018)
Giant cell arteritis (GCA) is a systemic vasculitis in individuals older than 50 years, characterized by headaches, visual disturbances, painful scalp, jaw claudication, impairment of limb arteries, and systemic inflammation, among other symptoms. GCA diagnosis is confirmed by a positive temporal artery biopsy (TAB) or by imaging modalities. A prominent acute phase response with inflammation is the hallmark of the disease, predominantly targeting large- and medium-sized arteries leading to stenosis or occlusion of arterial lumen. To date, there are no reliable tissue markers specific for GCA. Scarce reports have indicated the importance of epigenetics in GCA. The current systematic review reports significantly changed candidate biomarkers in TABs of GCA patients compared to non-GCA patients using qPCR.
Keyphrases
- systematic review
- giant cell
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- meta analyses
- physical activity
- photodynamic therapy
- dna methylation
- cancer therapy
- african american
- adverse drug
- fine needle aspiration
- binding protein